Why the study?
Patients with cardiac amyloidosis undergoing direct current electrical cardioversion are at risk of left atrial appendage thrombus, prompting investigation into thrombus formation rates, procedural success, and recurrence in transthyretin amyloid cardiomyopathy.
Patients with transthyretin amyloid cardiomyopathy have a high risk of left atrial appendage thrombus despite oral anticoagulation, necessitating routine TEE or CT prior to electrical cardioversion.
Answers are grounded in this paper and cite their sources.
LAAT despite OAC in ATTR-CM may support pre-DCCV imaging; leaves open whether routine screening improves outcomes.
Electrical Cardioversion in Transthyretin Amyloid Cardiomyopathy – Left Atrial Appendage Thrombi Despite Oral Anticoagulants: In a study involving 46 transthyretin amyloid cardiomyopathy patients, 62 electrical cardioversion procedures were conducted. Of these, 39 patients underwent transoesophageal echocardiography or computed tomography scans. Thrombus formation was identified in 8 cases (20.5%), including 5 patients (12.8%) who developed thrombi despite receiving anticoagulation therapy. The immediate success rate of cardioversion was 92.3% (n = 48), while the success rate at 3 months declined to 61.9% (n = 26). CT indicates computed tomography; TEE, transoesophageal echocardiography. Patients with cardiac amyloidosis undergoing direct current electrical cardioversion (DCCV) are at risk of left atrial appendage thrombus (LAAT). We investigated LAAT formation rates, success rates, and long-term recurrence rates in transthyretin amyloid cardiomyopathy (ATTR-CM) patients. ATTR-CM patients scheduled to undergo DCCV were included in the study. LAAT exclusion was performed utilizing transesophageal echocardiography or computed tomography. A total of 62 (1.35 per patient) DCCVs were recorded among 46 patients (77 ± 6.5 years, 89 % male) with ATTR-CM. In 39 DCCVs, LAAT exclusion was performed (62.9 %). In total, 10 DCCVs (16.1 %) were canceled due to (I) spontaneous conversion to sinus rhythm (n = 2, 5.1 %) or (II) definitive/suspected LAAT (n = 8, 20.5 %). Of these, five patients with LAAT had been receiving sufficient doses of oral anticoagulants for more than three weeks prior to DCCV. The immediate success rate was 92.3 %, and 3-month rhythm control was achieved in 27 (62.8 %) procedures. Notably, one stroke event was recorded two months following DCCV. A high rate of left atrial appendage thrombus was observed in ATTR-CM, leading to DCCV cancellation in 20.5% of patients. Despite a high immediate success rate (92.3%), sustained sinus rhythm control was achieved in only 62.8% following DCCV. These findings advise using TEE or CT prior to DCCV to exclude LAAT in ATTR-CM patients, even in those with oral anticoagulation.
No takes yet. Share an insight, caveat, or question.
Poledniczek et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: